Abstract: This document describes techniques and apparatuses directed at providing a tubular band with seamless lug integration for wearable devices. In aspects, the tubular band includes an extensible strap formed of interwoven fibers. The strap includes opposing outward-facing edges at opposing longitudinal ends. Each edge defines an opening within which a base section of a coupling device can reside. The coupling device further includes an attachment section, opposite the base section, which extends from the base section outwardly through the opening to engage a coupling connector of the wearable device. When the attachment section is connected to the coupling connector, the attachment section positions an end portion of the strap adjacent the opening to engage a surface of the wearable device. In this way, the strap can be coupled to a wearable device by positioning end portions of the strap against one or more surfaces of the wearable device, forming a seamless connection between the band and the wearable device.

Abstract: The invention relates to the uses of a new characterized TET protein showed restricted to N-terminus glycine residues exopeptidase. The invention also relates to a method comprising said use of said new characterized TET protein as a N-terminus glycine residues specific exopeptidase. The invention further relates to a support wherein it is immobilized on said new characterized TET protein as a N-terminus glycine residues specific exopeptidase.

Abstract: The invention relates to the uses of a new characterized TET protein showed restricted to N-terminus glycine residues exopeptidase. The invention also relates to a method comprising said use of said new characterized TET protein as a N-terminus glycine residues specific exopeptidase. The invention further relates to a support wherein it is immobilized on said new characterized TET protein as a N-terminus glycine residues specific exopeptidase.

Abstract: The invention relates to a composition comprising at least one first aminopeptidase and at least one second aminopeptidase, the first aminopeptidase representing up to 40% by weight relative to the total weight of the composition.

Abstract: The invention relates to the uses of a new characterized TET protein showed restricted to N-terminus glycine residues exopeptidase. The invention also relates to a method comprising said use of said new characterized TET protein as a N-terminus glycine residues specific exopeptidase. The invention further relates to a support wherein it is immobilized on said new characterized TET protein as a N-terminus glycine residues specific exopeptidase.

Abstract: The present invention relates to the use of a TET protein as a N-terminus aromatic amino acid residues specific exopeptidase, said TET protein comprising the amino acid sequence as set forth in SEQ ID NO: 1.

Abstract: The invention relates to cationic complexes made up of a lanthanide ion Ln3+ and a ligand of formula (I): with X, Y and R1 as defined in claim 1, and to the salts thereof with an anion, the solvates and hydrates thereof; with the exception of cationic complexes made up of a lanthanide ion Ln3+ and a ligand of one of formulae (I.1) or (I.4) as defined in claim 1, and the salts, solvates and hydrates thereof. The invention also relates to the use of such a complex or of a cationic complex made up of a lanthanide ion Ln3+ and a ligand of formula (I.1) or (I.4) as defined in claim 1, or of one of the salts thereof with an anion, the solvates or hydrates thereof, as an aid to the crystallisation of a biological macromolecule, as well as to crystallisation methods and methods for analysing or determining the structure of a biological macromolecule.

Abstract: The invention relates to cationic complexes made up of a lanthanide ion Ln3+ and a ligand of formula (I) : with X, Y and R1 as defined in claim 1, and to the salts thereof with an anion, the solvates and hydrates thereof; with the exception of cationic complexes made up of a lanthanide ion Ln3+ and a ligand of one of formulae (I.1) or (I.4) as defined in claim 1, and the salts, solvates and hydrates thereof. The invention also relates to the use of such a complex or of a cationic complex made up of a lanthanide ion Ln3+ and a ligand of formula (I.1) or (I.4) as defined in claim 1, or of one of the salts thereof with an anion, the solvates or hydrates thereof, as an aid to the crystallisation of a biological macromolecule, as well as to crystallisation methods and methods for analysing or determining the structure of a biological macromolecule.

Abstract: A fiber rotator mechanism for rotating a portion of an optical waveguide, specifically an optical fiber, about a longitudinal axis thereof comprises a motor having a tubular rotor through which the fiber extends, in use, and to which the fiber is secured, directly or indirectly. An optical fiber may be secured by means of a device which also compresses the optical fiber to induce a required birefringence, conveniently by means of a spring-loaded clamping device or a ferrule of shape memory material.

Abstract: A fiber rotator mechanism for rotating a portion of an optical waveguide, specifically an optical fiber, about a longitudinal axis thereof comprises a motor having a tubular rotor through which the fiber extends, in use, and to which the fiber is secured, directly or indirectly. An optical fiber may be secured by means of a device which also compresses the optical fiber to induce a required birefringence, conveniently by means of a spring-loaded clamping device or a ferrule of shape memory material.